<DOC>
	<DOCNO>NCT01720030</DOCNO>
	<brief_summary>We hypothesise levosimendan positive influence renal function acute kidney injury adult intensive care patient .</brief_summary>
	<brief_title>Levosimendan Acute Kidney Injury Study</brief_title>
	<detailed_description>The purpose trial evaluate whether use levosimendan able improve renal function .</detailed_description>
	<mesh_term>Wounds Injuries</mesh_term>
	<mesh_term>Acute Kidney Injury</mesh_term>
	<mesh_term>Simendan</mesh_term>
	<criteria>Clinically diagnose adult patient AKI Failure obtain write consent participate patient legal representative ( deferred consent ) Patients enter ICU postoperative observation estimate length stay le 24 hr . Moribund patient Patients age 18 Pregnancy Patients suffer preexist renal failure ( elevated NGAL value without apparent rise creatinine value ) Renal replacement therapy initiate admission due Chronic Kidney Disease Hypersensitivity levosimendan experience previous treatment Severe hypotension tachycardia Significant mechanical obstruction affect ventricular filling outflow . Severe hepatic impairment ( ALAT/ASAT &gt; 400U/L ) Patients exclude treat physician judge study participation undesirable medical , medicalethical reason Known history Torsades de Pointes</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Renal</keyword>
	<keyword>Acute Kidney Injury</keyword>
	<keyword>AKI</keyword>
	<keyword>Levosimendan</keyword>
	<keyword>Simdax</keyword>
	<keyword>Renal perfusion</keyword>
	<keyword>Mortality</keyword>
	<keyword>Renal flow</keyword>
</DOC>